Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9662342 | EUGIA PHARMA SPECLTS | Formulations of cyclophosphamide liquid concentrate |
Jun, 2035
(12 years from now) |
Drugs and Companies using CYCLOPHOSPHAMIDE ingredient
Market Authorisation Date: 25 August, 2021
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
5
United States
1
Korea, Republic of
1
Japan
1
Australia
1
Russia
1
Canada
1
China
1
Brazil
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic